This study aimed to determine the diagnostic accuracy of total Tau in plasma for AD, both for the clinical diagnosis of AD and predicting the probability of suffering from Alzheimer’s disease. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.